Drug Shortage Report for TWYNSTA
Report ID | 126582 |
Drug Identification Number | 02371049 |
Brand name | TWYNSTA |
Common or Proper name | TWYNSTA 80/5MG TABS, 4X7 |
Company Name | BOEHRINGER INGELHEIM (CANADA) LTD LTEE |
Market Status | MARKETED |
Active Ingredient(s) | TELMISARTAN AMLODIPINE |
Strength(s) | 80MG 5MG |
Dosage form(s) | TABLET |
Route of administration | ORAL ORAL |
Packaging size | BLISTER PACK 4X7 |
ATC code | C09DB |
ATC description | ANGIOTENSIN II ANTAGONISTS, COMBINATIONS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | 2020-10-26 |
Actual start date | 2020-10-23 |
Estimated end date | 2020-11-09 |
Actual end date | 2020-11-13 |
Shortage status | Resolved |
Updated date | 2020-11-14 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 5180 SOUTH SERVICE ROAD BURLINGTON, ONTARIO CANADA L7L 5H4 |
Company contact information | 1800 263 2425 |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v8 | 2020-11-14 | English | Compare |
v7 | 2020-11-13 | French | Compare |
v6 | 2020-11-13 | English | Compare |
v5 | 2020-10-24 | English | Compare |
v4 | 2020-10-23 | French | Compare |
v3 | 2020-10-23 | English | Compare |
v2 | 2020-10-16 | French | Compare |
v1 | 2020-10-16 | English | Compare |
Showing 1 to 8 of 8